Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex

Brain Res. 1992 Jul 3;584(1-2):322-4. doi: 10.1016/0006-8993(92)90914-u.

Abstract

Administered intraperitoneally to rats at 1 mg/kg, citalopram, a potent and selective inhibitor of serotonin uptake, significantly increased dialysate serotonin in the dorsal raphe, but not in the frontal cortex. At 10 mg/kg citalopram had a greater effect on raphe serotonin and a moderate and short-lasting increase in the dialysate serotonin in the frontal cortex. Citalopram 1 mg/kg i.p. significantly increased the extracellular concentration of serotonin in the frontal cortex of rats which had received a continuous infusion of 1 microM methiothepine in the dorsal raphe, a condition which by itself did not change cortical serotonin concentrations. The results suggest that the ability of serotonin uptake inhibitors to enhance the extracellular concentrations of serotonin in the dorsal raphe attenuates the drug's effect in the frontal cortex.

MeSH terms

  • Animals
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism*
  • Citalopram / pharmacology*
  • Extracellular Space / drug effects
  • Extracellular Space / metabolism*
  • Frontal Lobe / drug effects
  • Frontal Lobe / metabolism*
  • Injections, Intraperitoneal
  • Male
  • Methiothepin / pharmacology
  • Raphe Nuclei / drug effects
  • Raphe Nuclei / metabolism*
  • Rats
  • Rats, Inbred Strains
  • Serotonin / metabolism*

Substances

  • Citalopram
  • Serotonin
  • Methiothepin